28
Views
8
CrossRef citations to date
0
Altmetric
Original Article

The Role of Magnetic Resonance Spectroscopy in the Assessment of Kidney Viability

, &
Pages 487-492 | Received 09 Aug 1996, Accepted 22 Jan 1997, Published online: 09 Jul 2009

References

  • Bell J D, Cox I J, Sargentoni J, Marcus C D, Davidson B R, Bell J D. A 31P and 1H‐NMR investigation in vitro of normal and abnormal human liver. Biochim Biophys Acta 1993; 1225: 71–77
  • Belzer F O. Evaluation of preservation of the intra‐abdominal organs. Transplant Proc 1993; 25: 2527–2530
  • Bloch F, Hansen W W, Packard M E. Nuclear induction. Physics Rev 1946; 69: 127
  • Bretan P N, Vigneron D B, James T L, Williams R D, Hricak H, Juenemann K P, Yen T S, Tanagho E A. Assessment of renal viability by phosphorus‐31 magnetic resonance spectroscopy. J Urol 1986; 135: 866–871
  • Bretan P N, Vigneron D B, Hricak H, Juenemann K P, Williams R D, Tanagho E A, James T L. Assessment of renal preservation by phosphorus‐31 magnetic resonance spectroscopy: in vivo normothermic blood perfusion. J Urol 1986; 136: 1356–1359
  • Bretan P N, Vigneron D B, Hricak H, Collins G M, Price D C, Tanagho E A. Assessment of clinical renal preservation by phosphorus‐31 magnetic resonance spectroscopy. J Urol 1987; 137: 146–150
  • Bretan P N, Baldwin N, Novick A C, Majors A, Easley K, Ng T, et al. Pretransplantation assessment of renal viability by phosphorus‐31 magnetic resonance spectroscopy. Transplantation 1989; 48: 48–53
  • Bretan P N, Baldwin N, Martinez A, Stowe N, Scarpa A, Easley K, et al. Improved renal transplant preservation using a modified intracellular flush solution (PB‐2). Characterisation of mechanisms by renal clearance, high performance liquid chromatography, phosphorus‐31 magnetic resonance spectroscopy, and electron microscopy studies. Urol Res 1991; 19: 73–80
  • Changani K K, Fuller B J, Bell J D, Bryant D J, Moore D P, Taylor‐Robinson S D, Davidson B R. Hepatic nucleotide triphosphate regeneration following a period of brief hypothermic reperfusion in the pig model‐An in vitro 31P‐NMR study. Transplantation 1996; 62: 787–793
  • Changani K K, Fuller B J, Bryant D J, Bell J D, Ala‐Korpela M, Taylor‐Robinson S D, et al. Evaluation of ATP regeneration as an indicator of liver viability after cold storage: A 31P NMR study in pig liver. J Hepatol 1997; 26: 336–342
  • Ciancabilla F G, Pincernail J F, Defraigne J ‐O, Franssen C L, Carlier P G. The effect of technical conditions and storage medium composition on the phosphomonoesters to inorganic phosphate ratio determined by 31P nuclear magnetic resonance spectroscopy in rabbit kidney. Transplantation 1993; 56: 696–699
  • Cohen R D, Henderson R M, Iles R A, Monson J P, Smith J A. Metabolic acidosis. Ciba Foundation Symposium 84, Pitman, London 1982; 20
  • Dagnelie P C, Bell J D, Menon D K, Cox I J, Sargentoni J, Urenjak J, Iles R A. Effect of L‐alanine infusion on 31P magnetic resonance of the normal liver: towards in vivo biochemical pathology. Clin Sci 1992; 83: 183–190
  • Gupta R K, Moore R D. 31P NMR studies of intracellular free magnesium in the intact frog skeletal muscle. J Biol Chem 1980; 256: 3987–3993
  • Hené R J, van der Grond J, Boer W H, Mali W PT, Koomans H A. Pre‐transplantation assessment of renal viability with 31P magnetic resonance spectroscopy. Kidney Int 1994; 46: 1694–1699
  • Henze E, Lietzenmaver R, Kunz R, Schnur G, Clausen M, Schoser K, et al. ‐Prerequisites and initial experience for the non‐invasive routine evaluation of viability of experimental and human organ transplants by magnetic resonance spectroscopy. Transplant Proc 1990; 22: 2404–2408
  • Iles R A, Griffiths J R, Stevens A N. Perturbations in hepatic energy metabolism. Biochem Soc Trans 1985; 13: 843–845
  • Kootstra G, Wijnen R, van Hooff J P, van der Linden C J. Twenty percent more kidneys through a non‐heart‐beating program. Transplant Proc 1991; 23: 910–911
  • Kunikata S, Ishii T, Nishioka T, Uemura T, Kanda H, Matsuura T, et al. Measurement of viability in preserved kidneys with 31P NMR. Transplant Proc 1989; 21: 1269–1271
  • Nicholson M. Kidney transplantation from asystolic donors. Br J Hosp Med 1996; 55: 51–56
  • Nielsen M S. Elective ventilation. J Roy Coll Phys Lond 1994; 28: 85
  • Ploeg R J, van Bocket J H, Langendiijk F TH, Groenewegen M, van der Woude F J, Persijn G G, et al. Effect of preservation solution on results of cadaveric kidney transplantation. European Multicentre Study Group. Lancet 1992; 340: 129–137
  • Purcell E M, Torrey H C, Pound R V. Resonance absorption by nuclear magnetic moments in a solid. Phys Rev 1946; 69: 37–38
  • Radda G K, Rajagopalan B, Taylor D J. Biochemistry in vivo: an appraisal of clinical magnetic resonance spectroscopy. Magn Reson Q 1989; 5: 122–151
  • Riad H, Nicholls A, Neuberger J, Willatts S M, Sells R A, Jones M A, Francis R. Elective ventilation of potential organ donors. Br Med J 1995; 310: 714–718
  • Ross B D, Radda G K, Gadian D G, Rocker G, Esiri M, Falconer‐Smith J. Examination of a case of repeated McArdle's syndrome by 31P NMR. New Engl J Med 1981; 304: 1338–1342
  • Ruiz‐Cabello J, Cohen J S. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 1992; 5: 226–233
  • Sehr P A, Radda G K. A model kidney transplant studied by phosphorus nuclear magnetic resonance. Biochem Biophys Res Commun 1977; 77: 195–202
  • Sehr P A, Bore P J, Papatheofanis J, Radda G K. Nondestructive measurement of metabolites and tissue pH in the kidney by 31P nuclear magnetic resonance. Br J Exp Pathol 1979; 60: 632–641
  • Taylor D J, Bore P J, Styles P, Gadian D G, Radda G K. Bioenergetics of intact human muscle: a 31P nuclear magnetic resonance study. Mol Biol Med 1983; 1: 77–94
  • United Kingdom Transplant Support Services Authority. Yearly Transplant Statistics. UKTSSA, Bristol 1996
  • Varty K, Veitch P S, Morgan J DT, Kehinde E O, Donnelly P K, Bell P RF. Response to organ shortage: kidnev retrieval programme using non‐heart beating donors. Br Med J 1994; 308: 575
  • Wing A J, Chang R WS. Non‐heart beating donors as a source of kidneys. Br Med J 1994; 308: 549–550

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.